Document is current

Any future updates will be listed below

<i>CBLB</i> ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy

Crossref DOI link: https://doi.org/10.1136/jitc-2020-001975

Published Online: 2021-03-19

Published Print: 2021-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark